Volume 17, Number 10—October 2011
Books and Media
Antibiotic Resistance: Understanding and Responding to an Emerging Crisis
Highlight and copy the desired format.
|EID||Patel J. Antibiotic Resistance: Understanding and Responding to an Emerging Crisis. Emerg Infect Dis. 2011;17(10):1984. https://dx.doi.org/10.3201/eid1710.111066|
|AMA||Patel J. Antibiotic Resistance: Understanding and Responding to an Emerging Crisis. Emerging Infectious Diseases. 2011;17(10):1984. doi:10.3201/eid1710.111066.|
|APA||Patel, J. (2011). Antibiotic Resistance: Understanding and Responding to an Emerging Crisis. Emerging Infectious Diseases, 17(10), 1984. https://dx.doi.org/10.3201/eid1710.111066.|
FT Press, Upper Saddle River, NJ, USA, 2011
Pages: 288; Price: US $49.99
Interest in the problem of antimicrobial drug resistance was once limited to health care workers and academics. Today, the problem is widespread, and patients are acquiring drug-resistant infections for which there may be no active therapeutic agents. Antimicrobial drug–resistant infections, such as methicillin-resistant Staphylococcus aureus, have spread beyond health care settings and now cause disease, including life-threatening infections, in community settings.
The goal of Antibiotic Resistance: Understanding and Responding to an Emerging Crisis by Drlica and Perlin is to explain “how human activities contribute to the problem of resistance.” The book is intended for “farmers, hospital administrators, government regulators, health department personnel, pharmaceutical executives, and especially individual users” of antibiotics. The book is written in language that readers with a cursory understanding of biology will understand. Readers with little to no biology background can turn to helpful appendixes in the back of the book, where they will find a concise and clear introduction to the Molecules of Life and Microbial Life Forms, which provide the necessary information to tackle antibiotic resistance concepts.
The subject matter was not short-changed in the authors’ effort to make it more widely accessible. This book addresses resistance problems in all types of infections: bacterial, viral, parasitic, and fungal. Chapters address diverse issues, including antibiotic drug activity, development, and use; resistance mechanisms and transmission; laboratory detection of resistance; and what we can do to avoid drug-resistant pathogens.
The book’s readability is enhanced by the use of text boxes, which provide additional information such as historical antidotes that give depth to the chapter’s topic. For example, in Chapter 3, A Survey of Antibiotics, Box 3-2 recounts how a toxic formulation of sulfa drugs in the late 1937, which killed more than 100 persons, led Congress to pass the Food Drug and Cosmetic Act and to the subsequent creation of the Food and Drug Administration.
In addition, each chapter ends with a Perspective section that concisely positions the chapter’s topic in the larger world of humans, animals, pathogens, and drugs. This book fulfills its intended purpose and will serve as an important resource for anyone looking for greater understanding of antibiotics and the problem of drug resistance.
Please use the form below to submit correspondence to the authors or contact them at the following address:
Jean Patel, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G08, Atlanta, GA 30333, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: September 27, 2011
- Page last updated: September 27, 2011
- Page last reviewed: September 27, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)